ExcellGene SA
Paco Pino has extensive experience in research and development, currently serving as Director of R&D at ExcellGene SA since November 2018, following previous roles as Staff Scientist and Associate Director of Molecular Biology. Prior to this, Paco Pino was a Postdoctoral Researcher (Maître Assistant) at Université de Genève from January 2007 to November 2017 and completed a Postdoctoral fellowship at Imperial College London from 2004 to 2007. Paco Pino holds a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from Université Paris 6, earned between 2000 and 2003, and a Master's degree in Biochemistry and Molecular Biology from the University of Leiden, completed in 1999.
ExcellGene SA
Looking for a trusted partner in the development of cell lines and manufacturing processes? Look no further. With over 20 years of experience, we specialize in high-yielding (5-14 g/L), GMP-ready, CHO, and HEK293 cell lines for the production of biologics, biosimilars, and gene therapy (AAV, Adenovirus). We have a proven track record of expressing all types of proteins, including bi-specific mAb, Fc-fusions, viral proteins, cytokines, and more. Our team of scientists is ready to support your project from start to finish, including process development, analytical methods, scale-up, tox-batches, and Master Cell Banking. At our company, we pride ourselves on our commitment to quality and customer satisfaction. Contact us today to see how we can help you achieve your goals and be your trusted partner in cell line and process development.